Strikingly, the resulting Tau truncated isoform is reduced in Alzheimer’s disease patients’ brain, especially in later stages of the disease, in contrast to increasing total Tau levels. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.